Definium Therapeutics, Inc. (DFTX)
NASDAQ: DFTX · Real-Time Price · USD
17.45
+0.50 (2.95%)
At close: Feb 24, 2026, 4:00 PM EST
17.40
-0.05 (-0.26%)
After-hours: Feb 24, 2026, 7:39 PM EST
Definium Therapeutics Market Cap
Definium Therapeutics has a market cap or net worth of $1.72 billion as of February 24, 2026. Its market cap has increased by 161.33% in one year.
Market Cap
1.72B
Enterprise Value
1.55B
1-Year Change
161.33%
Ranking
Category
Stock Price
$17.45
Market Cap Chart
Since March 4, 2020, Definium Therapeutics's market cap has increased from $595.37M to $1.72B, an increase of 188.73%. That is a compound annual growth rate of 19.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 23, 2026 | 1.67B | 26.59% |
| Dec 31, 2025 | 1.32B | 158.44% |
| Dec 31, 2024 | 510.39M | 247.80% |
| Dec 29, 2023 | 146.75M | 77.54% |
| Dec 30, 2022 | 82.66M | -85.99% |
| Dec 31, 2021 | 590.17M | -82.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 4, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Syndax Pharmaceuticals | 1.73B |
| Zymeworks | 1.72B |
| Tango Therapeutics | 1.71B |
| MannKind | 1.71B |
| Veradermics | 1.68B |
| Immunocore Holdings | 1.66B |
| Oculis Holding AG | 1.66B |
| Kodiak Sciences | 1.65B |